Status:
COMPLETED
COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY)
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
University of California, Los Angeles
Conditions:
Pregnancy
Coronavirus
Eligibility:
FEMALE
13+ years
Brief Summary
PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a prospective cohort study of pregnant and recently pregnant women who are: either patients under investigation for COVID-19 or a confirmed case o...
Detailed Description
The investigators will recruit women age 13 or older under investigation for COVID-19 or with confirmed COVID-19 at any clinical state across the United States. Eligible participants will be identifie...
Eligibility Criteria
Inclusion
- Pregnant women or women who have been pregnant within the last 6 weeks
- Able to give informed consent
- Diagnosed with COVID-19; or being evaluated for COVID-19 ("patient under investigation") since January 1, 2020
Exclusion
- 1\. \<13 years of age.
Key Trial Info
Start Date :
March 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 26 2022
Estimated Enrollment :
1333 Patients enrolled
Trial Details
Trial ID
NCT04323839
Start Date
March 20 2020
End Date
April 26 2022
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143